THE INFLUENCE OF EDUCATION OF DRUG INFORMATION BY PHARMACIST ON THE IMPROVEMENT OF KNOWLEDGE AND THERAPEUTIC TARGET TO TYPE 2 DIABETES MELLITUS OUTPATIENTS IN HOSPITAL
DOI:
https://doi.org/10.22159/ijpps.2017v9i3.13682Keywords:
Pharmacist education, Diabetes mellitus, Knowledge, Therapeutic targetsAbstract
Objective: The study aims to determine the influence of education of drug information by the pharmacist on the improvement of knowledge and therapeutic target to type 2 diabetes mellitus outpatients in Dr. Moewardi Surakarta Hospital.
Methods: The research used the quasi-experimental method, repeated measure experiment design, pre-posttest design with the prospective patient data retrieval. 90 patients with type 2 diabetes mellitus were used as the subjects of the research divided into three groups (two test groups and one control group). In the test1 group, patients were educated about the drug information through leaflets and through oral explanation, the test 2 group through leaflets, and a control group through leaflets once at the beginning of the study. The study lasted for three months in which in every month fasting blood glucose levels (FBG) and blood glucose levels were analyzed within two hours after a meal (BG2PP) and given questionnaires knowledge to see the socio-demographic profile, knowledge, and blood glucose level of the patient. The data analysis used the statistical package for social sciences (SPSS) version 16 in the form of analysis Kolmogorov-Smirnov test and one-way anova test.
Results: The results showed that the education of the drug information by a pharmacist using leaflets and oral explanation in the test1 group was able to improve knowledge of type 2 diabetes mellitus outpatients in Dr. Moewardi Surakarta Hospital, in comparison to the leaflets giving information only to the test 2 group and control group. The education of drug information on the test 1 group was able to improve the patients' knowledge reaching 100%. Type 2 diabetes outpatients in the test 1 group could achieve a reduction in blood sugar levels, to the FBG level (136.47±36.08) mg/dl and BG2PP levels (193.43±58.21) mg/dl.
Conclusion: The education of drug information from the pharmacist had the influence to improves the knowledge and therapeutic target of type 2 diabetes mellitus outpatients in Dr. Moewardi Surakarta Hospital.
Downloads
References
Konstatenos P, Marciej B, Michael E, Nikolas P, Dimitrios P. Complication of diabetes. J Diabetes Res 2015;1-5. http://dx.doi.org/10.1155/2015/189525
Anon. Diabetes study and analysis. Data and Information Center of Indonesian Ministry of Health; 2014. p. 2-4.
Anon. Standards of medical care in diabetes. Diabetes Care 2005;28 Supp I:4-36.
Colagiuri R, Griffith R. National evidence-based guideline for patient education in type 2 diabetes The University of Sydney: Commonwealth of Australia; 2009.
Melanie JR. The pharmacist is talking with patients, a guide to patient counselling. British Columbia: William and Willkins Waverly Company; 1997. p. 105-6.
Patricia A, Richard C, Ken H, Jeannell M, Darryl R. The pharmacist’s role patient safety. Illinois: Department of Publication Joint Commission Resources; 2007. p. 1-17.
Andrew LW. Managing the patient with type II diabetes. Maryland: Aspen Publishers, Inc; 1997. p. 45-7.
Anon. Dr Moewardi Surakarta annual report in 2013. Data and Information Center of Dr Moewardi Surakarta Hospital; 2014. p. 3-7.
Okoro RN, Ngong CK. Evaluation of patient’s antidiabetic medication counseling provided by a pharmacist in a tertiary health care setting in Nigeria. Int Res J Pharm 2012;3:319-23.
Renuga E, Ramakrisnan SR, Vanitha RN, Thennasrasu P, Kannan G. Impact of continuous patient counselling on knowledge, attitude, and practice and medication adherence of diabetic patients attending outpatient pharmacy services. Asian J Pharm Clin Res 2016;9:364-9.
Ramesh A, Somashekar MA. Influence of structured patient education on therapeutic outcomes in diabetes and hypertensive patients. Asian J Pharm Clin Res 2010;3:174-8.
Marhanis SO, Kong LS. Diabetes knowledge and medication adherence among geriatric patient with type 2 diabetes mellitus. Int J Pharm Sci 2014;6:103-6.
Sesilia AK, Devi M. Antidiabetic drug use evaluation and drug-related problems (DRPs) in type 2 diabetes mellitus outpatient at Jakarta Hospital (abstract for II-Indonesian Conference on Clinical Pharmacy). Asian J Pharm Clin Res 2016;9:1-8.
Sharad T, Jayesh KR, Kajal S. Assesmet of the quality of life in patients of type 2 diabetes using the diabetes-39 questionnaire. Innovare J Health Sci 2016;4:3-5.
Deepraj P, Karthika P. Diabetes mellitus and its complications: a review. Int J Curr Pharm Res 2012;4:12-7.
Cara D, Erinmacpherson, Julie R. Effectiveness of telephone-delivered interventions for increasing physical activity levels in persons with type 2 diabetes or hypertension: a systematic review. J Crit Rev 2015;2:6-11.
Supratim DALU. Antihypertensive drug use in patients having comorbid diabetes: cross-sectional prescription pattern study in a tertiary care hospital. Asian J Pharm Clin Res 2010;3:43-5.
Yasser MK, Abbas MR, Saba HM. The effect of metformin on cytokines in Iraqi patients with type 2 Diabetes. Innovare J Medical Sci 2013;1:4-10.
Cristop R, Gabriele M. Critical evaluation of the role of acarbose in the treatment of diabetes: patient consideration. Dovepress J 2012;5:357-67.
Richard JM, Michael LA. Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. JCE and M 2009;8:1165-71.
Mohamad H, Grish T, Ateendra J, Surulivelrajan M. Study on prescribing pattern of anti-diabetic drugs among type 2 diabetes patients with complication in South Indian Teaching Hospital. Asian J Pharm Clin Res 2016;9:194-7.
Ashry G, Saud A, Mohanned S, Ali A, Azzam A, Meshari A, et al. Physicians’s instructions to patients regarding medications in Saudi University Hospital. Sci Res 2015;7:1441-7.
Published
How to Cite
Issue
Section
